Detalles de la búsqueda
1.
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Br J Cancer
; 126(6): 874-880, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937947
2.
Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.
BMC Cancer
; 20(1): 1164, 2020 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246428
3.
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Br J Cancer
; 121(5): 378-383, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31363167
4.
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Pharmacol Res
; 136: 133-139, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30213564
5.
Identification of new SNPs associated with severe toxicity to capecitabine.
Pharmacol Res
; 120: 133-137, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28347776
6.
Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi Technique.
J Natl Compr Canc Netw
; 14(5): 553-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160233
7.
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
BMC Cancer
; 15: 60, 2015 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886378
8.
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
BMC Cancer
; 15: 327, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925749
9.
Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan".
Pharmacol Res
; 145: 104288, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31141714
10.
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
Clin Transl Oncol
; 25(9): 2718-2731, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133732
11.
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement.
Clin Transl Oncol
; 25(12): 3378-3394, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37140736
12.
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.
Oncologist
; 17(3): 339-45, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22363067
13.
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies.
Ther Adv Med Oncol
; 14: 17588359221086911, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356259
14.
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Eur J Cancer
; 177: 154-163, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335783
15.
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.
Drugs Aging
; 38(3): 219-231, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33615402
16.
Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
Clin Colorectal Cancer
; 19(3): 165-177, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507561
17.
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials.
ESMO Open
; 4(6): e000599, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31803504
18.
Surgical resection of a solitary pancreatic metastasis from colorectal cancer: a new step to a cure?
Clin Colorectal Cancer
; 7(6): 398-401, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036693
19.
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 17(2): e323-e329, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29551560
20.
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer.
Eur J Cancer
; 90: 63-72, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29274618